As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

According to a new major clinical trial known as the ESSENCE trial, semaglutide—better known as Ozempic when used for Type 2 diabetes, or Wegovy when prescribed for weight loss—may be doing more for ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

Ozempic is an injectable semaglutide medication approved by the ... Adrienne Youdim, M.D., F.A.C.P. Weight Loss / Nutrition Dr. Adrienne Youdim is an internist who specializes in medical weight ...

NEW YORK (Reuters) -Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

Some say that Ozempic can lead to surprise pregnancies, referred to as "Ozempic babies," by increasing fertility. Learn what the research says and the risks of taking it during pregnancy.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal ...